Torrent Pharmaceuticals — 360° view

Torrent Pharmaceuticals, a company in the Pharmaceuticals industry, reported revenue of ₹4,979 crore and net profit of ₹534 crore for the September 2026 quarter.

Torrent Pharmaceuticals (NSE: TORNTPHARM) closed at ₹4,689.50 on 20 Nov 2026, up 26.0% over the past year. Its market capitalisation is ₹1,78,374 crore and it trades at 82.2 times earnings.

Share price
₹4,689.50 (20 Nov 2026)
Market cap
₹1,78,374 Cr (20 Nov 2026)
P/E
82.16 (20 Nov 2026)
Revenue
₹4,979 Cr (September 2026 quarter)
Net profit
₹534 Cr (September 2026 quarter)
ROCE
15.2% (FY26)
ROE
27.4% (FY26)
Book value
₹483 (FY26)
Dividend yield
0.81% (last 12 months to 20 Nov 2026)
52-week high / low
₹5,250.00 / ₹3,672.30 (20 Nov 2026)
1-year return
26.0% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: TORNTPHARM

Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations. It is the flagship company of Torrent Group which also has presence in power and city gas distribution businesses.

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.